IM Cannabis (IMCC) EBT (2020 - 2026)
IM Cannabis (IMCC) posted quarterly EBT of -$1.8 million for Q1 2026, down 1897.4% year-over-year from $101749.8 in Q1 2025, and up 75.47% quarter-over-quarter from -$7.5 million in Q4 2025.
IM Cannabis (IMCC) EBT (2020 - 2026) Analysis & Trends
IM Cannabis' EBT history runs 7 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, EBT fell 1897.4% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$12.9 million (down 631.82% YoY), while the FY2025 annual figure was -$10.2 million, down 5.52% from the prior year.
- EBT for Q1 2026 stood at -$1.8 million, up from -$7.5 million in the prior quarter.
- The five-year high for EBT was $3.3 million in Q3 2022, with the low at -$31.2 million in Q4 2022.
- The 5-year median for EBT is -$1.8 million (2026), against an average of -$4.2 million.
- The sharpest annual moves came in 2022 and 2026: EBT surged 164.1% in 2022, then plunged 1897.4% in 2026.
- IM Cannabis' EBT stood at -$31.2 million in 2022, then surged by 58.55% to -$12.9 million in 2023, then jumped by 90.75% to -$1.2 million in 2024, then slumped by 522.84% to -$7.5 million in 2025, then surged by 75.47% to -$1.8 million in 2026.
- Business Quant data shows IMCC's EBT at -$1.8 million in Q1 2026, -$7.5 million in Q4 2025, and -$2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.20 Mn |
| Mar 31, 2026 | -1.83 Mn |
| Dec 31, 2025 | -7.45 Mn |
| Sep 30, 2025 | -2.71 Mn |
| Jun 30, 2025 | -920,183.44 |
| Mar 31, 2025 | 101,749.81 |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -812,223.18 |
| Jun 30, 2024 | 143,303.55 |
| Mar 31, 2024 | -4.55 Mn |
| Dec 31, 2023 | -12.94 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | -2.88 Mn |
| Mar 31, 2023 | -652,412.19 |
| Dec 31, 2022 | -31.21 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | -3.69 Mn |
| Mar 31, 2022 | -5.77 Mn |
| Dec 31, 2021 | -2.66 Mn |
| Sep 30, 2021 | -5.18 Mn |